Transthyretin Cardiac Amyloidosis in HFpEF

Clinical trial NCT03414632 · COMPLETED

Trial details

NCT number: NCT03414632
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Heart Failure With Preserved Ejection Fraction

Start date: 2017-12-01
Primary completion: 2020-03-31
Enrollment: 287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.